paclitaxel has been researched along with Hemolysis in 81 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.23) | 18.7374 |
| 1990's | 2 (2.47) | 18.2507 |
| 2000's | 12 (14.81) | 29.6817 |
| 2010's | 58 (71.60) | 24.3611 |
| 2020's | 8 (9.88) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, YJ; Kim, S; Kim, SJ; Kim, SS; Lee, BJ | 1 |
| Chanotiya, CS; Darokar, MP; Faridi, U; Khanuja, SP; Krishna, V; Kumar, JK; Luqman, S; Negi, AS; Saxena, HO; Srivastava, S | 1 |
| Chen, Z; Cui, Y; Duan, H; Feng, Y; Han, L; Tong, X; Yang, S; Zhu, Y | 1 |
| Chen, Z; Duan, H; Han, L; Hsu, P; Lee, KH; Liu, W; Morris-Natschke, SL; Tong, X; Yang, S | 1 |
| Chen, J; Cheng, B; Deng, X; Li, G; Li, L; Mai, R; Ren, Y; Yu, D; Yu, Z; Zhang, C | 1 |
| Chablani, L; Gupta, U; Jeswani, G; Nakhate, KT; Sahoo, RK | 1 |
| Adams, KN; Ahmed, SJ; Akaputra, R; Akosman, I; Akya, A; Ali, S; Aminuddin, A; An, B; An, X; Anana, EV; Ao, L; Arany, Z; Arena, R; Azhar, A; Azhar, W; Baasankhuu, A; Bae, WK; Bahar, B; Balaji, L; Barbosa, M; Batchu, UR; Berg, KM; Berlin, N; Berthier, E; Bettiol, AA; Bi, B; Bodie, D; Borges, VF; Borghi-Silva, A; Bowman, CE; Brantly, M; Budhathoki, L; Bukhari, A; Cabeza, M; Cao, J; Cao, Q; Cao, S; Carrasco-Nuñes, N; Caruso, FR; Carvalho, C; Chakrabarty, D; Chandra Mondal, P; Chandran, V; Chang, P; Chase, M; Chauhan, AS; Chauhan, PS; Che, J; Cheemalamarri, C; Chen, D; Chen, H; Chen, J; Chen, Q; Chen, X; Chen, Z; Chetri, BK; Cho, SW; Choi, TI; Chung, HC; Cocchi, MN; Collins, LC; Colombo, N; Come, SE; Custodio, JM; Dai, TY; De La Garza Ramos, R; de Oliveira, CR; Dębczak, A; DeMuri, GP; Deng, J; Deng, K; Dhanani, LY; Diaz, S; Djaharuddin, I; Dong, G; Dong, Q; Donnino, MW; Dwiyanti, R; Elango, KP; Eleswarapu, A; Evans, EGB; Fachri, M; Fang, Y; Fantappiè, G; Farasat, A; Farsida, F; Fathimah, A; Febrianti, A; Feng, S; Fernandes, V; Fernandez Garcia, E; Fleming, GF; Foskett, JK; Fourman, MS; Fu, M; Fu, W; Fukushima, S; Gahlay, GK; Gai, S; Gao, R; Gao, W; Gilbert, DM; Gong, J; Gong, MN; Gong, Z; González-Cavieres, L; Gordon, SE; Goudarzi, F; Goulart, CDL; Greenstein, AE; Grigg, ARC; Grilli, D; Grisham, RN; Grossestreuer, AV; Grzęda, A; Grzegorczyk, A; Gu, J; Guo, H; Gupta, R; Haldar, A; Hamid, Y; Han, HJ; Hancock, CN; Hassan, GW; Hatta, M; He, D; He, F; He, J; Heidarinia, H; Helmchen, G; Herrera-Lavados, C; Hieber, DL; Hoehr, C; Hou, L; Huang, C; Huang, J; Hussain, S; Imaoka, S; Indoliya, Y; Jain, E; Jana, S; Jang, H; Jang, HS; Jara-Quijada, E; Jeacopello, I; Jeung, HC; Jiang, B; Jiang, D; Jiang, G; Jiang, L; Jiang, Q; Jiang, Y; Jiang, Z; Jiao, Z; Jr, JCB; Jung, M; Jung, S; Junita, AR; Kalavathi, A; Kang, X; Kannan, R; Kato, K; Khadka, M; Khan, AR; Khan, I; Khodayari, N; Kim, BJ; Kim, CG; Kim, CH; Kim, D; Kim, H; Kim, HS; Kim, HT; Kim, TS; Kim, YT; King, R; Koh, K; Konkol, M; Koo, DH; Kretzschmar, R; Krop, IE; Kuang, Y; Kubeneck, LJ; Kulkarni, K; Kumar, N; Kunjan, C; Kwon, WS; Lai, C; Lans, A; Lascano, J; Lavania, UC; Lee, CK; Lee, DA; Lee, HS; Lee, J; Lee, KH; Lee, MS; Lee, SW; Lee, UN; Lemus-Mondaca, R; Li, HR; Li, J; Li, Q; Li, X; Li, Y; Li, Z; Liang, H; Liang, Y; Lin, L; Lin, Y; Lipsyc-Sharf, M; Liu, B; Liu, C; Liu, DX; Liu, H; Liu, J; Liu, K; Liu, S; Liu, X; Liu, Z; Locknane, MP; Lorusso, D; Lü, H; Luo, Z; Lv, X; Ma, Y; Mandava, K; Manfrinetti, P; Mao, W; Marques-Sá, J; Masaki, T; Massi, MN; Matsuse, M; Matulonis, UA; Maxwell, CA; McAssey, EV; McManamen, AM; Mehl, RA; Mendes, RG; Meng, Z; Miao, Z; Miller, S; Milovanovic, S; Mishra, SK; Mitra, S; Mitsutake, N; Miyazaki, Y; Moriwaki, S; Mortenson, R; Moskowitz, A; Mudring, AV; Mues Genannt Koers, L; Muhammad, S; Muhimpundu, S; Murapaka, C; Murota, H; Mv, S; Nakazawa, Y; Nam, CM; Natzir, R; Ngo, L; Nguyen, DD; Nie, Y; Nishigori, C; Noji, MC; Notini, L; Oaknin, A; Ogi, T; Oguro, A; Okukawa, K; Olawaiye, AB; Omble, AD; Oso, T; Page, CA; Palma-Acevedo, A; Pani, M; Parikh, SM; Park, J; Park, S; Partridge, AH; Pashova, HI; Paudel, U; Paulssen, E; Payero, L; Peng, M; Peppercorn, JM; Pérez-Won, M; Pitarresi, JR; Pradhan, J; Prevost, D; Primaguna, MR; Puvvada, N; Qian, D; Rajaure, YS; Rajca, A; Rajput, N; Rana, SR; Rangan, L; Ranjbarian, P; Redd, PS; Ren, T; Rha, SY; Riley, L; Romano, M; Rong, X; Rosenberg, SM; Rostamian, M; Rothwell, KA; Ru, S; Ruddy, KJ; Rustgi, AK; Salam, A; Sankaran, S; Santoso, A; Saravanakumar, P; Satheeshkumar, K; Schapira, L; Schulz, K; Senapati, A; Senju, C; Sharma, P; Shelke, RG; Shen, F; Shen, X; Shen, Y; Sheteiwy, MS; Shetty, PR; Shi, L; Shi, MM; Shiigi, H; Shimada, M; Shinkawa, VAM; Shtender, V; Siswanto, FM; Smetana, V; Snow, C; Sridiana, E; Stephenson, MW; Stoll, S; Su, X; Sun, S; Sun, XF; Surapaneni, JR; Suri, K; Świątek, Ł; Syukri, A; Tabilo-Munizaga, G; Takezawa, MG; Tamimi, RM; Tamura, A; Tanaka, K; Tang, M; Tao, Y; Tateishi, S; Thapa, B; Theberge, AB; ThomasArrigo, LK; Thongpang, S; Tiwari, M; Tong, Q; Totton, RR; Tripathi, RD; Tsujimoto, M; Tu, WC; Tudor, IC; Tyskiewicz, K; Ubaidah, FM; Ulhassan, Z; Utani, A; Van Gorp, T; Veerapandian, V; Vennila, KN; von Gunten, U; Wagle, N; Waks, AG; Wald, ER; Wang, B; Wang, D; Wang, H; Wang, L; Wang, W; Wang, X; Wang, Y; Wang, Z; Warner, E; Waterhouse, GIN; Weiss, J; Weissenrieder, JS; Wellen, KE; Wu, JY; Xiang, W; Xiao, S; Xie, Q; Xu, F; Xu, TW; Xu, Y; Yan, B; Yan, JM; Yang, D; Yang, P; Yang, S; Yang, W; Yao, Y; Yassari, R; Yong, Q; Yu, H; Yu, Z; Yun, UJ; Zagotta, WN; Zang, DY; Zanudo, JGT; Zeng, A; Zhang, H; Zhang, R; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YT; Zhao, C; Zhao, J; Zhong, S; Zhou, F; Zhou, W; Zhou, Y | 1 |
| Jiao, M; Ju, C; Lin, H; Qu, D; Qu, G; Tian, C; Xue, J; Xue, L; Zhang, C | 1 |
| Cui, F; Han, Y; Kawashima, Y; Li, S; Liang, N; Liu, J; Sun, S; Yan, P | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Chen, F; Chen, K; Li, Y; Pan, W; Qiao, S; Tan, G; Yang, Y; Zhang, L | 1 |
| Ge, Z; Han, M; Ji, X; Li, J; Luo, B; Sun, X; Wang, Q; Zhang, W; Zhou, K | 1 |
| Adabi, M; Bergonzi, MC; Esnaashari, SS; Khosravani, M; Madani, F; Webster, TJ; Younes, HM | 1 |
| Acker, JP; Chen, J; Gu, Q; Gu, W; Kong, B; Patra, P; Wei, L; Yang, X | 1 |
| Gao, L; Lu, W; Nan, L; Peng, T; Sun, J; Sun, L; Wang, H; Wang, J; Wang, Y; Xiao, Y; Yan, Z; Yu, L; Zhang, L; Zhou, J | 1 |
| Chen, B; Chen, J; Chen, L; Deng, L; Gao, B; Wu, C; Yao, J; Yu, N; Zhang, Y; Zhou, Q | 1 |
| Choudhury, SR; Dev, A; Karmakar, S; Kaundal, B; Singh, PK; Srivastava, AK | 1 |
| Lee, RJ; Teng, L; Wang, L; Xu, C; Yao, J; Yu, B; Yu, G; Zhang, X; Zhang, Y | 1 |
| Deng, C; Jiang, C; Lee, RJ; Xu, C; Yao, JU; Yu, BO; Zhang, X; Zhang, Y | 1 |
| Francis, AP; Gurudevan, S; Jayakrishnan, A | 1 |
| Ingle, SG; Monpara, JD; Pai, RV; Vavia, PR | 1 |
| Bahadur, P; Jha, PK; Kansara, V; Patil, R; Tiwari, S; Tripathi, R | 1 |
| Chaurasiya, B; He, W; Mohammad, IS; Teng, C; Wu, C; Yin, L | 1 |
| Chakrabarti, R; Cooke, BM; Coppel, RL; Patankar, S; Rawat, PS | 1 |
| Choi, C; Jang, JY; Jang, MK; Kim, TH; Nah, JW; Nam, JP; Park, SC | 1 |
| Jain, NK; Jain, S; Kesharwani, P; Tekade, RK | 1 |
| Banerjee, R; Deshmukh, A; Joshi, N; Shanmugam, T | 1 |
| Ge, L; Wang, J; Wang, Y; Xu, H; Zhu, J | 1 |
| Lam, KS; Luo, J; Nangia, S; Shi, C; Xu, G; Yuan, D | 1 |
| Chuan, X; Dai, W; Lu, J; Wang, X; Zhang, H; Zhang, Q | 1 |
| Alam, N; Dubey, RD; Gupta, PN; Jain, S; Khare, V; Kour, S; Nehate, C; Saneja, A; Singh, SK | 1 |
| Chen, Y; Huang, Y; Li, J; Li, S; Venkataramanan, R; Zhang, P; Zhang, X; Zhao, W | 1 |
| Kulhari, H; Mukherjee, S; Pooja, D; Rachamalla, SS; Singh, MK; Sistla, R | 1 |
| Chauhan, AS; Kumar, M; Tekade, M; Tekade, RK | 1 |
| Chen, X; Li, M; Lin, J; Liu, H; Lv, S; Song, W; Tang, Z; Zhang, D | 1 |
| Cao, Z; Feng, ST; Jiang, Q; Liu, J; Wang, W; Xie, X; Xu, M; Zhang, C; Zhu, W | 1 |
| Gao, H; He, Q; Liu, Y; Mei, L; Ran, R; Zhang, L; Zhang, Q; Zhang, Z | 1 |
| Bora, HK; Chourasia, MK; Datta, D; Meher, JG; Panchal, SB; Pawar, VK; Sharma, K; Singh, A; Singh, P; Singh, Y | 1 |
| Han, J; Jiang, J; Xu, M; Zhang, D; Zhang, J; Zhang, X | 1 |
| Fallon, JK; Fu, Q; He, Z; Liu, D; Liu, F; Ma, Y; Wang, Y; Yang, X; Zhang, D | 1 |
| Dalela, M; Kharbanda, S; Shrivastav, TG; Singh, H | 1 |
| Chen, W; He, Z; Huang, J; Ma, J; Shi, Z; Sun, W; Xia, J; Zhang, X | 1 |
| Cai, H; Cui, B; Huo, M; Liu, J; Wang, L; Yin, L; Yin, T; Zhou, J | 1 |
| El Kourati, F; Kesharwani, SS; Kumar, S; Muley, P; Tummala, H | 1 |
| Fan, Y; Meng, N; Su, Y; Tan, J; Xiao, Y; Zhang, M; Zhou, N | 1 |
| Alasino, RV; Beltramo, DM; Garro, AG; Heredia, V; Leonhard, V; Maggio, B | 1 |
| Ding, Y; Gu, X; Hua, P; Shen, L; Wang, R; Yin, L; Zhou, J | 1 |
| Afzal, M; Alamgir, K; Bano, S; Nazir, S; Waraich, MM | 1 |
| Gauthier, MA; Leroux, JC; Polomska, A | 1 |
| Dehghankelishadi, P; Dorkoosh, FA; Gholami, M; Pordeli, M; Ravar, F; Saadat, E; Safavi, M | 1 |
| Cui, C; Li, M; Lv, H; Wang, W; Yin, L; Zhang, Z; Zhou, J | 1 |
| Burt, H; Letchford, K; Liggins, R; Wasan, KM | 1 |
| Huo, MR; Liu, FJ; Liu, H; Lü, L; Zhang, Y; Zhou, JP | 1 |
| Chi, SC; Choi, HG; Koo, YB; Lee, WM; Lee, WS; Park, JH; Woo, JS; Yong, CS | 1 |
| Gong, J; Huo, M; Li, J; Peng, X; Yu, D; Zhang, H; Zhang, Y; Zhou, J | 1 |
| He, M; Tang, C; Yin, C; Yin, L; Zhao, Z | 1 |
| Domb, AJ; Levy, Y; Mandler, D; Tal, N; Tzemach, G; Weinberger, J | 1 |
| Bathula, SR; Conwell, C; Huang, L; Liu, F; Liu, Y; Park, JY; Zhang, Y | 1 |
| Gajbhiye, V; Jain, K; Jain, NK; Kesharwani, P; Tekade, RK | 1 |
| Bansal, KK; Gupta, U; Jain, NK; Kakde, D | 1 |
| Jain, S; Tiwary, AK; Utreja, P | 1 |
| Chen, J; Deng, L; Liang, H; Lu, J; Yang, Q | 1 |
| Li, G; Liu, J; Mao, L; Pang, Y; Sun, J; Wang, R; Yan, D; Zhu, X | 1 |
| Clementi, C; Mero, A; Miller, K; Pasut, G; Satchi-Fainaro, R | 1 |
| Dong, TA; Gonik, AM; Kato, J; Lam, KS; Lee, JS; Li, Y; Luo, J; Xiao, K; Xiao, W | 1 |
| Cui, Z; He, B; Qu, W; Wang, JC; Wang, YB; Zhang, H; Zhang, JY; Zhang, Q | 1 |
| Jiang, X; Liu, J; Van, S; Wang, J; Wang, Y; Yang, D; Yu, L | 1 |
| Cui, F; Fang, L; Li, X; Liang, N; Piao, H; Sun, S | 1 |
| Feng, L; Hu, L; Li, Y; Yin, Q; Zhang, P; Zhang, Z | 1 |
| Cao, F; Huang, A; Li, H; Li, S; Ping, Q; Su, Z; Sun, M; Xiao, Y; Zhang, C | 1 |
| Jain, NK; Jain, V; Kaul, A; Mishra, AK; Mishra, PR; Swarnakar, NK; Verma, A | 1 |
| Alasino, RV; Beltramo, DM; Bianco, ID; Garro, AG; Heredia, V; Leonhard, V | 1 |
| Liu, H; Yao, J; Zhang, L; Zhang, Q; Zhou, J | 1 |
| Andringa, G; Egberts, AC; Fens, MH; Gaillard, CA; Rasmussen, JT; Sachini, N; Schiffelers, RM; Vader, P; van Oirschot, BA; van Solinge, WW; van Wijk, R | 1 |
| Abebe, L; Bhagwati, N; Jain, D; Marcoullis, G; Talusan, R; Wiernik, PH | 1 |
| Bilensoy, E; Doğan, AL; Gürkaynak, O; Hincal, AA | 1 |
| Chow, DS; Nornoo, AO; Osborne, DW | 1 |
| Ding, Q; Guo, Q; Ping, Q; Qu, G; Shen, Z; Sun, Y; Wu, X; Yao, Z; Yuan, S; Zhang, C; Zhou, H | 1 |
| Lundberg, BB | 1 |
| Ishibe, A; Itai, S; Jinno, S; Kawahara, H; Miwa, A; Nakano, M; Yamahira, T | 1 |
| Sambandan, TG; Tarr, BD; Yalkowsky, SH | 1 |
1 review(s) available for paclitaxel and Hemolysis
2 trial(s) available for paclitaxel and Hemolysis
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Acute Kidney Injury; Adult; Aged; Albumins; Alloys; Amides; Amino Acids; Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bioaccumulation; Blood Glucose; Brain; Brassica napus; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Catalysis; Child; China; Chlorides; Chlorine; Chromium; Chronic Disease; Cohort Studies; Copper; Corrosion; COVID-19; Creatinine; Dermatitis; Diabetes Mellitus; Diazepam; Disease-Free Survival; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Dyspnea; Electron Spin Resonance Spectroscopy; Environmental Monitoring; Escherichia coli; Escherichia coli Infections; Esophageal Neoplasms; Esophagogastric Junction; Estradiol; Exercise Test; Exercise Tolerance; Female; Ferric Compounds; Fishes; Food Chain; gamma-Aminobutyric Acid; Genomics; Halogenation; HEK293 Cells; Hemolysis; Heterocyclic Compounds; Hospitalization; Humans; Hydrogen Peroxide; Hyperglycemia; Introns; Iron; Kidney; Kinetics; Laboratories; Limit of Detection; Lipopolysaccharides; Liver Neoplasms; Magnesium; Male; Mammals; Materials Testing; Mercury; Metal-Organic Frameworks; Methylmercury Compounds; Mice; Microscopy, Electron, Scanning; Mifepristone; Minerals; Molecular Weight; Mutation; Nanoparticles; Neuroprotection; NF-kappa B; Nitrates; Nitrogen; NLR Family, Pyrin Domain-Containing 3 Protein; Orthopedics; Ovarian Neoplasms; Ovariectomy; Oxidation-Reduction; Oxidative Stress; Oxygen; Oxygen Consumption; Paclitaxel; Phenols; Progesterone; Prospective Studies; Proteins; Protons; Pulmonary Disease, Chronic Obstructive; Ramucirumab; Rats; Receptor, ErbB-2; Respiratory Function Tests; Retrospective Studies; Saliva; SARS-CoV-2; Seeds; Sesbania; Shock, Septic; Silicon Dioxide; Sleep; Soil; Specimen Handling; Spectroscopy, Mossbauer; Spin Labels; Staphylococcus aureus; Stomach Neoplasms; Streptococcus mutans; Thiamine; Toll-Like Receptor 2; Toll-Like Receptor 4; Trastuzumab; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; Water; Water Pollutants, Chemical; Water Purification; Xeroderma Pigmentosum; Zebrafish | 2023 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
79 other study(ies) available for paclitaxel and Hemolysis
| Article | Year |
|---|---|
In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Apoptosis; Cell Division; Cell Line, Tumor; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Erythrocytes; Escherichia coli; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Klebsiella pneumoniae; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Paclitaxel; Peptides; Protein Precursors; Salmonella typhimurium | 2003 |
Gallic acid-based indanone derivatives as anticancer agents.
Topics: Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Erythrocytes; Gallic Acid; Hemolysis; Humans; Indans; Inhibitory Concentration 50; Models, Chemical; Osmosis; Tetrazolium Salts; Thiazoles | 2008 |
The derivatives of Pulsatilla saponin A, a bioactive compound from Pulsatilla chinensis: Their synthesis, cytotoxicity, haemolytic toxicity and mechanism of action.
Topics: A549 Cells; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Hemolysis; Humans; Pulsatilla; Saponins; Structure-Activity Relationship | 2017 |
Cytotoxicity, Hemolytic Toxicity, and Mechanism of Action of Pulsatilla Saponin D and Its Synthetic Derivatives.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cytotoxins; Erythrocytes; G1 Phase; Hemolysis; Humans; KB Cells; Lung Neoplasms; MCF-7 Cells; Rabbits; Saponins; Structure-Activity Relationship | 2018 |
Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Membrane Permeability; Cell Proliferation; Cell-Penetrating Peptides; Drug Carriers; Drug Compounding; Drug Liberation; Hemolysis; Humans; MCF-7 Cells; Mice; Molecular Targeted Therapy; Neoplasms, Experimental; Paclitaxel; Receptors, LHRH; Tubulin | 2021 |
Development and optimization of paclitaxel loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics.
Topics: Animals; Antineoplastic Agents; Blood Coagulation; Breast Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; Half-Life; Hemolysis; Humans; Injections, Intravenous; Male; MCF-7 Cells; Nanoparticles; Nanotechnology; Paclitaxel; Polylactic Acid-Polyglycolic Acid Copolymer; Polymethacrylic Acids; Rats, Wistar; Tissue Distribution | 2021 |
Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment.
Topics: Animals; Chitosan; Delayed-Action Preparations; Drug Carriers; Gene Expression Regulation, Neoplastic; Hemolysis; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Male; Materials Testing; Mice; Micelles; Molecular Targeted Therapy; Paclitaxel; PC-3 Cells; Prostatic Neoplasms; Receptors, sigma; Sigma-1 Receptor; Xenograft Model Antitumor Assays | 2020 |
Tumor-targeting and redox-sensitive micelles based on hyaluronic acid conjugate for delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disulfides; Drug Delivery Systems; Hemolysis; Humans; Hyaluronic Acid; In Vitro Techniques; MCF-7 Cells; Mice; Micelles; Microscopy, Electron, Transmission; Neoplasms; Oxidation-Reduction; Paclitaxel; Polyethylene Glycols; Polymers; Rabbits; Tetrazolium Salts; Thiazoles; X-Ray Diffraction | 2020 |
Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Drug Delivery Systems; Drug Liberation; Endocytosis; Female; Folic Acid; Glutathione; Hemolysis; Humans; Hyaluronic Acid; MCF-7 Cells; Mice; Micelles; Molecular Targeted Therapy; NIH 3T3 Cells; Oxidation-Reduction; Paclitaxel; Polymers; Rabbits; Xenograft Model Antitumor Assays | 2020 |
Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Drug Carriers; Drug Liberation; Endocytosis; Erythrocytes; Folic Acid; Hemolysis; Humans; Lipoproteins; Mice; Nanoparticles; Neoplasms; Paclitaxel; Particle Size; Rabbits; Serum Albumin, Bovine; Static Electricity | 2020 |
Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Topics: Animals; Antineoplastic Agents; Apolipoproteins; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Drug Compounding; Drug Liberation; Endocytosis; Glioblastoma; Hemolysis; Humans; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Methotrexate; Nanoparticles; Paclitaxel; Polylactic Acid-Polyglycolic Acid Copolymer; Proto-Oncogene Proteins c-bcl-2; Rats | 2020 |
Nanoformulated water-soluble paclitaxel to enhance drug efficacy and reduce hemolysis side effect.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Carriers; Female; HeLa Cells; Hemolysis; Hexoses; Humans; Mice, Nude; Micelles; Neoplasms; Paclitaxel; Poloxamer; Solubility; Water | 2017 |
Erythrocyte Membrane-Wrapped pH Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy.
Topics: Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Carriers; Drug Liberation; Erythrocyte Membrane; Half-Life; Hemolysis; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Nanoparticles; Paclitaxel; Particle Size; Polyglutamic Acid; Polymers | 2017 |
An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Emulsions; Female; Hemolysis; Humans; Lipids; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Rabbits; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2017 |
1, 3β-Glucan anchored, paclitaxel loaded chitosan nanocarrier endows enhanced hemocompatibility with efficient anti-glioblastoma stem cells therapy.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chitosan; Drug Liberation; Glucans; Hemolysis; Humans; Nanoparticles; Paclitaxel | 2018 |
Delivery of paclitaxel using nanoparticles composed of poly(ethylene oxide)-b-poly(butylene oxide) (PEO-PBO).
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Epoxy Compounds; Hemolysis; Humans; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Paclitaxel; Polyethylene Glycols; Rats, Sprague-Dawley; Tissue Distribution; Xenograft Model Antitumor Assays | 2018 |
A Novel Paclitaxel-Loaded Polymeric Micelle System with Favorable Biocompatibility and Superior Antitumor Activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Delivery Systems; Hemolysis; Humans; Male; Mice, Nude; Micelles; Neoplasms; Paclitaxel; Particle Size; Polymers; Rats, Sprague-Dawley; Tumor Burden | 2018 |
Amphotericin B-albumin conjugates: Synthesis, toxicity and anti-fungal activity.
Topics: Amphotericin B; Antifungal Agents; Cell Line; Drug Carriers; Erythrocytes; HEK293 Cells; Hemolysis; Humans; Microbial Sensitivity Tests; Paclitaxel; Serum Albumin, Bovine; Serum Albumin, Human; Solubility; Yeasts | 2018 |
Liposils: An effective strategy for stabilizing Paclitaxel loaded liposomes by surface coating with silica.
Topics: Amines; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Cholesterol; Drug Liberation; Drug Stability; Erythrocytes; Hemolysis; Humans; Liposomes; Male; Melanoma, Experimental; Mice; Paclitaxel; Phosphatidylcholines; Rats, Sprague-Dawley; Silicon Dioxide | 2018 |
Functionalized graphene nanosheets with improved dispersion stability and superior paclitaxel loading capacity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbodiimides; Drug Carriers; Drug Compounding; Drug Liberation; Erythrocytes; Ethylenediamines; Folic Acid; Graphite; Hemolysis; Hydrophobic and Hydrophilic Interactions; Kinetics; Mice; Nanostructures; Oxides; Paclitaxel; Sodium Chloride | 2019 |
Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Disulfiram; Drug Carriers; Drug Combinations; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Erythrocytes; Female; Hemolysis; Humans; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Paclitaxel; Rats, Sprague-Dawley; Tissue Distribution; Tumor Burden | 2019 |
Cellular effects of curcumin on Plasmodium falciparum include disruption of microtubules.
Topics: Binding Sites; Colchicine; Curcumin; Dose-Response Relationship, Drug; Drug Synergism; Erythrocytes; Hemolysis; Humans; Microtubules; Molecular Docking Simulation; Paclitaxel; Plasmodium falciparum; Protein Binding; Protein Conformation; Protein Multimerization; Tubulin; Tubulin Modulators; Vinblastine | 2013 |
Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Hemolysis; Humans; Lauric Acids; Micelles; Paclitaxel; Rats; Transferrin | 2013 |
One platform comparison of solubilization potential of dendrimer with some solubilizing agents.
Topics: Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Dendrimers; Excipients; Hemolysis; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Paclitaxel; Solubility; Time Factors; Toxicity Tests | 2015 |
Apoptotic cascade inspired lipid nanovesicles show synergism with encapsulated paclitaxel in chemoresistant colon carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Chemistry, Pharmaceutical; Colonic Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Female; Hemolysis; Humans; Mice; Mice, Nude; Nanocapsules; Nanomedicine; Nanotechnology; Paclitaxel; Phosphatidylserines; Protein Binding; Rats; Rats, Wistar | 2014 |
Development of a thermally responsive nanogel based on chitosan-poly(N-isopropylacrylamide-co-acrylamide) for paclitaxel delivery.
Topics: Acrylic Resins; Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Endocytosis; Erythrocytes; Gels; Hemolysis; HT29 Cells; Humans; Mice; Nanostructures; Paclitaxel; Rats, Sprague-Dawley; Transition Temperature; Xenograft Model Antitumor Assays | 2014 |
A structure-property relationship study of the well-defined telodendrimers to improve hemocompatibility of nanocarriers for anticancer drug delivery.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Hemolysis; HT29 Cells; Humans; Mice; Mice, Nude; Micelles; Molecular Dynamics Simulation; Nanostructures; Paclitaxel; Polymers; Xenograft Model Antitumor Assays | 2014 |
Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Erythrocytes; Female; Hemolysis; Humans; MCF-7 Cells; Mice; Mice, Nude; Micelles; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Solubility; Surface Properties; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |
Development and evaluation of paclitaxel loaded PLGA:poloxamer blend nanoparticles for cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Drug Discovery; Drug Stability; Hemolysis; Humans; Lactic Acid; MCF-7 Cells; Nanoparticles; Paclitaxel; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Temperature | 2014 |
PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.
Topics: Animals; Breast Neoplasms; Disease Models, Animal; Drug Carriers; Farnesol; Female; HCT116 Cells; Hemolysis; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Micelles; Paclitaxel; Polyethylene Glycols; Salicylates | 2014 |
Dendrimer-TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes.
Topics: Animals; Cell Death; Cell Line; Cell Survival; Dendrimers; Docetaxel; Hemolysis; Humans; Hydrogen-Ion Concentration; Micelles; Paclitaxel; Particle Size; Polyethylene Glycols; Rats; Solubility; Spectroscopy, Fourier Transform Infrared; Static Electricity; Taxoids; Vitamin E; X-Ray Diffraction | 2014 |
Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Chemistry, Pharmaceutical; Dendrimers; Dose-Response Relationship, Drug; Drug Carriers; Drug Stability; Hemolysis; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Jurkat Cells; Kinetics; MCF-7 Cells; Microtubules; Nanoparticles; Nanotechnology; Neoplasms; Paclitaxel; Particle Size; Solubility; Surface Properties; Technology, Pharmaceutical; Tubulin Modulators | 2015 |
Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Disulfides; Drug Delivery Systems; Hemolysis; Humans; Hydrogen-Ion Concentration; Lysine; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micelles; Oxidation-Reduction; Paclitaxel; Pentetic Acid; Polyethylene Glycols; Polymers | 2014 |
Stable cerasomes for simultaneous drug delivery and magnetic resonance imaging.
Topics: Antineoplastic Agents; Cell Survival; Drug Delivery Systems; Erythrocytes; HeLa Cells; Hemolysis; Humans; Liposomes; Magnetic Resonance Imaging; Magnetite Nanoparticles; Paclitaxel; Silicon Dioxide | 2014 |
Simultaneous delivery of therapeutic antagomirs with paclitaxel for the management of metastatic tumors by a pH-responsive anti-microbial peptide-mediated liposomal delivery system.
Topics: Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Erythrocytes; Gene Silencing; Hemolysis; Hydrogen-Ion Concentration; Liposomes; Mice, Inbred BALB C; MicroRNAs; Neoplasms; Paclitaxel; Rats; Tissue Distribution; Tumor Burden; Wound Healing | 2015 |
Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Compounding; Emulsions; Female; Hemolysis; Humans; Macrophages; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Rats; Rats, Wistar; Th1 Cells; Th2 Cells; Vitamin E | 2014 |
Polymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxel.
Topics: Animals; Cell Death; Chitin; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescence; Hemolysis; Hep G2 Cells; Humans; Mice; Microscopy, Confocal; Nanoparticles; Oligosaccharides; Paclitaxel; Particle Size; Polymers; Proton Magnetic Resonance Spectroscopy; Rabbits; Spectroscopy, Fourier Transform Infrared; Static Electricity; Tretinoin | 2015 |
Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Disulfides; Drug Carriers; Erythrocytes; Hemolysis; Humans; Hydrolysis; Mice; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasms; Paclitaxel; Particle Size; Polyethylene Glycols; Prodrugs; Tissue Distribution; Vitamin E | 2015 |
pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Biocompatible Materials; Blood Cell Count; Body Weight; Carcinoma, Ehrlich Tumor; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Drug Liberation; Drug Stability; Endocytosis; Erythrocyte Aggregation; Hemolysis; Hydrogen-Ion Concentration; In Situ Nick-End Labeling; Inhibitory Concentration 50; Kaplan-Meier Estimate; Maleates; Maximum Tolerated Dose; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polystyrenes; Tissue Distribution | 2015 |
Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blood; Blood Coagulation; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line; Cisplatin; Complement Activation; Drug Carriers; Drug Compounding; Folic Acid; Hemolysis; Humans; Leukocyte Count; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Polyesters; Polyethylene Glycols; Rabbits; Xenograft Model Antitumor Assays | 2016 |
Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Delivery Systems; Erythrocytes; Hemolysis; Humans; Lethal Dose 50; Mice; Nanoparticles; Neoplasms; Paclitaxel; Polyethylene Glycols; Rabbits; Serum Albumin; Suspensions; Tissue Distribution; Treatment Outcome | 2016 |
Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Erythrocytes; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Inulin; Male; Melanoma, Experimental; Mice, Inbred C57BL; Micelles; Paclitaxel; Tumor Burden | 2016 |
Hydroxypropyl-β-cyclodextrin-graphene oxide conjugates: Carriers for anti-cancer drugs.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Cell Survival; Drug Carriers; Erythrocytes; Graphite; Hemolysis; Humans; Hydrogen-Ion Concentration; Microscopy, Atomic Force; Oxides; Paclitaxel; Solubility; Spectroscopy, Fourier Transform Infrared | 2016 |
Sialoganglioside Micelles for Enhanced Paclitaxel Solubility: In Vitro Characterization.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Centrifugation; Drug Design; Drug Stability; Excipients; Freeze Drying; Freezing; Gangliosides; Hemolysis; Humans; Hydrolysis; In Vitro Techniques; Micelles; Paclitaxel; Particle Size; Solubility | 2016 |
Green design "bioinspired disassembly-reassembly strategy" applied for improved tumor-targeted anticancer drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Drug Compounding; Drug Delivery Systems; Erythrocytes; Female; Green Chemistry Technology; Hemolysis; Hep G2 Cells; Humans; Lipids; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Paclitaxel; Rabbits; Rats, Sprague-Dawley; Tumor Burden | 2016 |
Paclitaxel loaded magnetic nanocomposites with folate modified chitosan/carboxymethyl surface; a vehicle for imaging and targeted drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Chitosan; Drug Delivery Systems; Drug Liberation; Erythrocytes; Ferric Compounds; Folic Acid; Hemolysis; Humans; Magnetic Phenomena; MCF-7 Cells; Nanocomposites; Neoplasms; Nickel; Paclitaxel; Serum Albumin, Bovine | 2016 |
In Vitro and In Vivo Evaluation of PEGylated Layer-by-Layer Polyelectrolyte-Coated Paclitaxel Nanocrystals.
Topics: Animals; Cell Death; Cell Survival; Coated Materials, Biocompatible; Colloids; Female; Hemolysis; HT29 Cells; Humans; Kinetics; Mice, Nude; Nanoparticles; Paclitaxel; Polyelectrolytes; Polyethylene Glycols; Tissue Distribution | 2017 |
In vitro and in vivo evaluation of paclitaxel-lapatinib-loaded F127 pluronic micelles.
Topics: Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Hemolysis; Lapatinib; Male; Mice; Mice, Inbred BALB C; Micelles; Paclitaxel; Poloxamer; Quinazolines; Rats; Rats, Sprague-Dawley; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Design, synthesis and evaluation of multi-functional tLyP-1-hyaluronic acid-paclitaxel conjugate endowed with broad anticancer scope.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Hemolysis; Humans; Hyaluronan Receptors; Hyaluronic Acid; Paclitaxel; Rabbits | 2017 |
In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Chemical Precipitation; Dialysis; Drug Carriers; Hemolysis; Humans; In Vitro Techniques; Micelles; Molecular Weight; Nanoparticles; Paclitaxel; Particle Size; Polyesters; Polyethylene Glycols; Solubility; Tissue Distribution; Viscosity | 2009 |
[Solubilizing and sustained-releasing abilities and safety preliminary evaluation for paclitaxel based on N-octyl-O, N-carboxymethyl chitosan polymeric micelles].
Topics: Animals; Antineoplastic Agents, Phytogenic; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Guinea Pigs; Hemolysis; Humans; Hypersensitivity, Immediate; Male; Mice; Micelles; Nanoparticles; Paclitaxel; Particle Size; Polymers | 2008 |
Toxicity studies of cremophor-free paclitaxel solid dispersion formulated by a supercritical antisolvent process.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Chemistry, Pharmaceutical; Chromatography, Supercritical Fluid; Creatinine; Dose-Response Relationship, Drug; Excipients; Female; Glycerol; Hemolysis; Injections, Intravenous; Kidney; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Organ Size; Paclitaxel; Polyethylene Glycols; Powders; Rats; Rats, Sprague-Dawley; Technology, Pharmaceutical | 2009 |
Synthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micelles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Hemolysis; Humans; Micelles; Paclitaxel; Rabbits; Serum Albumin | 2009 |
Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line; Cell Line, Tumor; Cell Survival; Cerium; Drug Carriers; Enbucrilate; Hemolysis; Humans; Hyaluronic Acid; Magnetic Resonance Spectroscopy; Male; Materials Testing; Mice; Mice, Inbred Strains; Microscopy, Electron, Transmission; Nanoparticles; Nitrates; Paclitaxel; Particle Size; Rabbits; Sarcoma 180; Spectroscopy, Fourier Transform Infrared; Static Electricity; X-Ray Diffraction | 2009 |
Drug-eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer.
Topics: Adhesiveness; Angioplasty, Balloon; Animals; Antineoplastic Agents, Phytogenic; Benzene Derivatives; Blood Vessels; Cell Adhesion; Cell Survival; Coated Materials, Biocompatible; Diazonium Compounds; Drug-Eluting Stents; Electric Impedance; Electrochemistry; Fullerenes; Hemolysis; In Vitro Techniques; Materials Testing; Metals; Microscopy, Electron, Scanning; Paclitaxel; Polymers; Rabbits; Spectrometry, X-Ray Emission | 2009 |
Targeted cancer therapy with novel high drug-loading nanocrystals.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carrier Proteins; Chemistry, Pharmaceutical; Drug Delivery Systems; Excipients; Female; Folate Receptors, GPI-Anchored; Glycerol; Hemolysis; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Neoplasm Transplantation; Neoplasms; Paclitaxel; Poloxamer; Receptors, Cell Surface; Surface-Active Agents | 2010 |
Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison.
Topics: Biological Assay; Cell Death; Cell Survival; Dendrimers; Dextrans; Flow Cytometry; Folic Acid; Galactose; HeLa Cells; Hemolysis; Humans; Ligands; Neoplasms; Organ Specificity; Paclitaxel; Polypropylenes | 2011 |
Development and characterization of triazine based dendrimers for delivery of antitumor agent.
Topics: Alanine Transaminase; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Dendrimers; Drug Delivery Systems; Hemolysis; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Mice; Mice, Inbred BALB C; Nuclear Magnetic Resonance, Biomolecular; Paclitaxel; Solubility; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Triazines | 2010 |
Localized delivery of paclitaxel using elastic liposomes: formulation development and evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Delayed-Action Preparations; Elasticity; Glycerol; Hemolysis; Liposomes; Male; Paclitaxel; Rabbits; Rats; Skin Absorption; Spectroscopy, Fourier Transform Infrared; Toxicity Tests | 2011 |
Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Cell Line, Tumor; Drug Carriers; Drug Stability; Emulsions; HeLa Cells; Hemolysis; Humans; Injections, Intravenous; Micelles; Paclitaxel; Particle Size; Phospholipids; Polysorbates; Rabbits; Rats; Rats, Sprague-Dawley; Soybean Oil | 2011 |
Polymeric micelles with water-insoluble drug as hydrophobic moiety for drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Compounding; Drug Delivery Systems; Erythrocytes; Female; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Mice, Nude; Micelles; Neoplasm Transplantation; Neoplasms; NIH 3T3 Cells; Paclitaxel; Polyesters; Rats; Solubility; Surface-Active Agents; Water | 2011 |
Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
Topics: Alendronate; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dendrimers; Drug Carriers; Female; Hemolysis; Humans; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Paclitaxel; Polyethylene Glycols; Rats | 2011 |
Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Cross-Linking Reagents; Disease Models, Animal; Disulfides; Drug Delivery Systems; Female; Hemolysis; Humans; Kinetics; Mice; Mice, Nude; Micelles; Models, Biological; Ovarian Neoplasms; Paclitaxel; Particle Size; Spectroscopy, Near-Infrared; Tissue Distribution; Xenograft Model Antitumor Assays | 2011 |
Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Cattle; Cell Line, Tumor; Drug Carriers; Female; Hemolysis; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Nanoparticles; Neoplasms; Niacinamide; Paclitaxel; Phenylurea Compounds; Pyridines; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine; Sorafenib | 2011 |
Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Stability; Erythrocyte Aggregation; Female; Hemolysis; Humans; Male; Mice; Mice, Nude; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Paclitaxel; Proteins; Random Allocation; Thermogravimetry; Xenograft Model Antitumor Assays | 2011 |
α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Spectroscopy; Male; Mice; Micelles; Microscopy, Electron, Transmission; Paclitaxel; Particle Size; Rabbits; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; Tocopherols; Uterine Cervical Neoplasms | 2012 |
Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Chemical Phenomena; Drug Carriers; Drug Compounding; Erythrocytes; Glioma; Hemolysis; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Micelles; Paclitaxel; Polyesters; Rats; Rats, Sprague-Dawley; Survival Analysis; Tissue Distribution; Transferrin | 2012 |
An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arginine; Cell Line, Tumor; Cell Membrane; Cell Survival; Cells, Cultured; Drug Carriers; Erythrocytes; Hemolysis; Humans; Hydrogen-Ion Concentration; Lipids; Lysosomes; Male; Mice; Nanoparticles; Neoplasms; Paclitaxel; Rats; Serum Albumin, Bovine; Tissue Distribution | 2012 |
Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cryoelectron Microscopy; Crystallization; Drug Carriers; Drug Delivery Systems; Female; Glycerides; Hemolysis; Liquid Crystals; Male; Mice; Nanoparticles; Nanotechnology; Paclitaxel; Polyethylene Glycols; Rabbits; Rats; Scattering, Radiation; Technetium; Time Factors | 2012 |
Self-assembled micelles of monosialogangliosides as nanodelivery vehicles for taxanes.
Topics: Antineoplastic Agents; Blood Platelets; Cells, Cultured; Docetaxel; Drug Carriers; Drug Stability; Erythrocytes; Gangliosides; Hemolysis; Humans; Micelles; Nanostructures; Paclitaxel; Platelet Aggregation; Solubility; Taxoids | 2012 |
Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and Paclitaxel based on hyaluronic acid-based multifunctional nanocarrier.
Topics: Animals; Apoptosis; Cells, Cultured; Drug Carriers; Female; Flow Cytometry; Hemolysis; Hep G2 Cells; Humans; Hyaluronic Acid; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Rabbits; Tretinoin | 2013 |
Taxol(®)-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor(®) EL.
Topics: Cells, Cultured; Chemistry, Pharmaceutical; Erythrocytes; Flow Cytometry; Glycerol; Hemolysis; Human Umbilical Vein Endothelial Cells; Humans; Paclitaxel; Phosphatidylserines | 2013 |
Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case report.
Topics: Adenocarcinoma; Anemia, Hemolytic; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Docetaxel; Female; Hemolysis; Humans; Methylprednisolone; Middle Aged; Paclitaxel; Plasmapheresis; Taxoids | 2002 |
Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Caproates; Cell Line; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Erythrocytes; Fibroblasts; Hemolysis; Humans; Mice; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nanoparticles; Paclitaxel; Particle Size; Static Electricity; Surface Properties | 2008 |
Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Emulsions; Excipients; Female; Hemolysis; Humans; In Vitro Techniques; Injections, Intravenous; Male; Oils; Paclitaxel; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Reference Standards; Solubility; Surface-Active Agents | 2008 |
Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Topics: Alkanesulfonic Acids; Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Biological Availability; Carcinoma, Ehrlich Tumor; Carcinoma, Lewis Lung; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Hemolysis; Humans; Liver Neoplasms, Experimental; Male; Materials Testing; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Micelles; Paclitaxel; Rats; Rats, Sprague-Dawley; Safety; Sarcoma 180; Tissue Distribution | 2008 |
Ether lipids enhance the cytotoxic effect of teniposide and paclitaxel in liposomes against leukaemic cells in culture.
Topics: Antineoplastic Agents, Phytogenic; Drug Antagonism; Drug Synergism; Hemolysis; HL-60 Cells; Humans; Jurkat Cells; Liposomes; Paclitaxel; Phospholipid Ethers; Phosphorylcholine; Teniposide | 1997 |
Development of novel chitosan derivatives as micellar carriers of taxol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Chitin; Chitosan; Dogs; Drug Carriers; Erythrocytes; Hemolysis; Injections, Intravenous; Lauric Acids; Membrane Potentials; Micelles; Paclitaxel; Particle Size; Solubility | 1998 |
A new parenteral emulsion for the administration of taxol.
Topics: Alkaloids; Animals; Chemistry, Pharmaceutical; Emulsions; Hemolysis; Infusions, Parenteral; Mice; Paclitaxel; Pharmaceutical Vehicles; Triacetin; Triglycerides | 1987 |